AI assistant
Sending…
AtriCure, Inc. — Director's Dealing 2013
Mar 15, 2013
31802_dirs_2013-03-15_680d0a98-9d32-4341-bd2e-d6053d0e5bac.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4/A — Form 4/A
Issuer: AtriCure, Inc. (ATRC)
CIK: 0001323885
Period of Report: 2013-03-11
Reporting Person: WHITE ROBERT S. (Director)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2013-03-11 | Stock Option (right to buy) | $8.48 | A | 50000 | Acquired | 2023-03-11 | Common Stock (50000) | Direct |
Footnotes
F1: Exercisable cumulatively at a rate of 25% per annum commencing on the anniversary of the date of grant. This amendment is being filed solely to correct the vesting schedule that was previously disclosed.
F2: Not applicable
More from AtriCure, Inc.
Regulatory Filings
2026
May 27
Regulatory Filings
2026
May 19
Interim / Quarterly Report
2026
May 6
Regulatory Filings
2026
May 5
Proxy Solicitation & Information Statement
2026
Apr 6
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3